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Abstract
Clostridium difficile is emerging as pathogen in man as well as in animals. In 2000 it was described as a cause of neo-
natal enteritis in piglets and it is now the most common cause of neonatal diarrhoea in the USA. In Europe, C. difficile in-
fection (CDI) in neonatal piglets has also been reported. Diagnosis of this infection is based on detection of the bacterium 
or its toxins A and B. Most detection methods, however, are only validated for diagnosing human infections. In this study 
three commercially available Enzyme Immuno Assays and a commercial RT-PCR were evaluated by testing 172 pig faecal 
specimens. The results of each test were compared with cytotoxicity assays (CTA) and toxigenic culture as gold standards. 
Compared with CTA, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were for 
RT-PCR respectively 91.6%, 37.1%, 57.6%, and 82.5%, and for Premier Toxin A+B (Meridian): 83.1%, 31.5%, 53.1% 
and 66.7%, and for Immunocard tox A/B (Meridian) 86.6%, 56.8%, 66.9%, and 80.7%, and for VIDAS (BioMérieux): 
54.8%, 92.6%, 85.0%, and 72.8%.
Compared with toxigenic culture sensitivity, specificity, PPV and NPV were; for RT-PCR 93.0%, 34.7%, 50.0%, and 
87.5%, and for Premier Toxin A+B: 80.3%, 27.7%, 43.8%, and 66.7%, and for Immunocard tox A/B: 80.0%, 46.2%, 
52.8% and 75.4%, and for VIDAS: 56.4%, 89.8%, 77.5%, and 76.7%.
We conclude that all tests had an unacceptable low performance as a single test for detection of C. difficile in pig herds 
and that a two step algorithm is necessary. Of all assays, the RT-PCR had the highest NPV compared to both reference 
methods and is therefore the most appropriate test to screen for absence of C. difficile in pigs as a first step in the algo-
rithm. The second step would be a confirmation of the positive results by toxigenic culture.  
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Abstract
The aim of this study was to support a risk assessment of MRSA-isolates from swine using a diagnostic DNA-microarray 
to detect virulence-, toxin- and resistance related genes. In comparison with other species like poultry, cattle and humans 
there were only few isolates with virulence genes. 
Introduction
Methicillin- resistant Staphylococcus aureus (MRSA) is an important pathogenic agent causing nosocomial infections. The 
clonal lineage ST398-MRSA-V dominates in swine, in humans with occupational exposure to swine and in regions with 
intensive swine production (Tenhagen, B.-A. et al. 2009). Investigation of their antimicrobial resistance and SCCmec 
typing produced multiple analogue results. The aim of this study was to detect virulence-, toxin- and resistance related 
genes of swine isolates to support a risk assessment, in particular with respect to the transmission to humans.
Material and Methods
We used DNA-chip-technology based on the STAPHY TYPE Kit (Alere Technologies GmbH, Jena) which identifies 333 
clinically relevant markers for resistance and virulence in a single test.
After a linear PCR amplification the resulting single stranded and biotin labelled amplicons are stringently hybridised to a 
set of highly discriminative probes that are covalently bound onto the microarrays. Additionally, the phenotypic resistance 
of 71 isolates was investigated by broth microdilution to compare the genotypic and phenotypic resistance profiles. 83 
isolates from swine and 48 isolates from other species were included in this genotype characterisation.
Results and Discussion
The tests showed a good correlation between genotype and phenotype resistance. The array provides information about 
genes for PVL, toxic shock syndrome, exfoliativ toxins and enterotoxins and in addition resistance genes for example 
pleuromutiline and streptothricin. 10 of 131 investigated isolates contained virulence genes; only 2 of them were isolated 
from pigs. Within one spa-type we can discriminate a lot of different resistance gene patterns. For example in 39 isolates 
of the Spa-type t011 we investigated 16 different resistance gene patterns.
This microarray-technique is useful for risk assessment in veterinary diagnostic like it is in human medicine (Monecke et al, 
2008) and it also provides information for epidemiological studies. 
Conclusion
Only 2,4% of the investigated isolates from swine showed virulence genes for enterotoxin, and none was positive for 
PVL, toxic shock syndrome or exfoliativ toxins. The isolates showed good correlation between phenotypic and genotypic 
resistance. The DNA-Chip-technology provides essential information for epidemiological studies in a one step analysis.
Acknowledgment: This study was performed within the framework INTERREG-IVa Euregio-project Safeguard MRSAVet-
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